PD-L1 expression in penile cancer: a new frontier for immune checkpoint inhibitors?

被引：5
|
作者：
Al-Ahmadie, H. [1 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, Dept Pathol, 1275 York Ave, New York, NY 10021 USA
来源：
ANNALS OF ONCOLOGY | 2016年 / 27卷 / 09期
关键词：
NIVOLUMAB; IPILIMUMAB; CARCINOMA; PEMBROLIZUMAB; OPPORTUNITIES; BLADDER; CELLS;
D O I：
10.1093/annonc/mdw268
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1658 / 1659
页数：2
相关论文
共 50 条
  • [41] Immune checkpoint inhibitors: a new frontier in bladder cancer
    Max Kates
    Nikolai A. Sopko
    Hotaka Matsui
    Charles G. Drake
    Noah M. Hahn
    Trinity J. Bivalacqua
    [J]. World Journal of Urology, 2016, 34 : 49 - 55
  • [42] Immune checkpoint inhibitors and prostate cancer: a new frontier?
    Modena, Alessandra
    Ciccarese, Chiara
    Iacovelli, Roberto
    Brunelli, Matteo
    Montironi, Rodolfo
    Fiorentino, Michelangelo
    Tortora, Giampaolo
    Massari, Francesco
    [J]. ONCOLOGY REVIEWS, 2016, 10 (01)
  • [43] Immune checkpoint inhibitors: a new frontier in bladder cancer
    Kates, Max
    Sopko, Nikolai A.
    Matsui, Hotaka
    Drake, Charles G.
    Hahn, Noah M.
    Bivalacqua, Trinity J.
    [J]. WORLD JOURNAL OF UROLOGY, 2016, 34 (01) : 49 - 55
  • [44] PD-1/PD-L1 immune checkpoint: Potential target for cancer therapy
    Dermani, Fatemeh K.
    Samadi, Pouria
    Rahmani, Golebagh
    Kohlan, Alisa K.
    Najafi, Rezvan
    [J]. JOURNAL OF CELLULAR PHYSIOLOGY, 2019, 234 (02) : 1313 - 1325
  • [45] Immunohistochemistry of Immune Checkpoint Markers PD-1 and PD-L1 in Prostate Cancer
    Sharma, Meenal
    Yang, Qi
    Mcmahon, Loralee
    Miyamoto, Hiroshi
    [J]. MODERN PATHOLOGY, 2019, 32
  • [46] Immunohistochemistry of Immune Checkpoint Markers PD-1 and PD-L1 in Prostate Cancer
    Sharma, Meenal
    Yang, Qi
    Mcmahon, Loralee
    Miyamoto, Hiroshi
    [J]. LABORATORY INVESTIGATION, 2019, 99
  • [47] Predictive effect of PD-L1 expression for immune checkpoint inhibitor (PD-1/PD-L1 inhibitors) treatment for non-small cell lung cancer: A meta-analysis
    Zhang, Binbin
    Liu, Yi
    Zhou, Sijing
    Jiang, Huihui
    Zhu, Ke
    Wang, Ran
    [J]. INTERNATIONAL IMMUNOPHARMACOLOGY, 2020, 80
  • [48] Immunohistochemistry of immune checkpoint markers PD-1 and PD-L1 in prostate cancer
    Sharma, Meenal
    Yang, Zhiming
    Miyamoto, Hiroshi
    [J]. MEDICINE, 2019, 98 (38)
  • [49] PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
    Hartkopf, Andreas D.
    Taran, Florin-Andrei
    Wallwiener, Markus
    Walter, Christina B.
    Kraemer, Bernhard
    Grischke, Eva-Maria
    Brucker, Sara Y.
    [J]. BREAST CARE, 2016, 11 (06) : 385 - 390
  • [50] Cancer cell expression of CCR2 regulates the PD-L1/PD-1 immune checkpoint in breast cancer
    Fein, Miriam R.
    Almeida, Ana S.
    Eberhardt, Anais
    Egeblad, Mikala
    [J]. CANCER IMMUNOLOGY RESEARCH, 2016, 4 (01)
12345